See more : Transcend Information, Inc. (2451.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Titan Pharmaceuticals, Inc. (TTNP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Titan Pharmaceuticals, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Noranda Aluminum Holding Corporation (NORNQ) Income Statement Analysis – Financial Results
- Bausch + Lomb Corporation (BLCO.TO) Income Statement Analysis – Financial Results
- Kyushu Electric Power Company, Incorporated (9508.T) Income Statement Analysis – Financial Results
- Watani Iron Steel Co. (9513.SR) Income Statement Analysis – Financial Results
- China Oriental Group Company Limited (CUGCY) Income Statement Analysis – Financial Results
Titan Pharmaceuticals, Inc. (TTNP)
About Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 184.00K | 60.00K | 1.53M | 4.84M | 3.61M | 5.91M | 215.00K | 15.07M | 1.67M | 3.65M | 10.48M | 7.12M | 4.07M | 10.09M | 79.00K | 70.00K | 24.00K | 32.00K | 89.00K | 31.00K | 89.00K | 2.89M | 4.57M | 1.88M | 300.00K | 100.00K | 17.50M | 300.00K | 100.00K |
| Cost of Revenue | 112.00K | 196.00K | 199.00K | 472.00K | 1.29M | 538.00K | 9.65M | 6.13M | 4.68M | 4.08M | 8.31M | 10.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -196.00K | -400.00K | -300.00K | -400.00K | -500.00K | -300.00K |
| Gross Profit | 72.00K | -136.00K | 1.33M | 4.37M | 2.32M | 5.37M | -9.43M | 8.94M | -3.00M | -429.00K | 2.17M | -3.49M | 4.07M | 10.09M | 79.00K | 70.00K | 24.00K | 32.00K | 89.00K | 31.00K | 89.00K | 2.89M | 4.57M | 2.08M | 700.00K | 400.00K | 17.90M | 800.00K | 400.00K |
| Gross Profit Ratio | 39.13% | -226.67% | 86.96% | 90.24% | 64.33% | 90.90% | -4,387.44% | 59.34% | -179.77% | -11.77% | 20.72% | -49.08% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 110.43% | 233.33% | 400.00% | 102.29% | 266.67% | 400.00% |
| Research & Development | 1.91M | 4.76M | 5.69M | 5.92M | 7.24M | 7.48M | 9.65M | 6.13M | 4.68M | 4.08M | 8.31M | 10.61M | 11.21M | 12.86M | 2.46M | 16.24M | 12.24M | 11.62M | 17.77M | 20.42M | 22.26M | 29.82M | 23.34M | 16.74M | 9.40M | 7.80M | 18.80M | 5.60M | 0.00 |
| General & Administrative | 5.55M | 6.03M | 4.99M | 5.80M | 5.40M | 0.00 | 5.07M | 4.60M | 3.76M | 3.05M | 3.06M | 4.88M | 3.37M | 3.26M | 3.44M | 9.76M | 6.21M | 4.86M | 5.37M | 5.24M | 5.11M | 5.08M | 5.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 6.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.55M | 6.03M | 4.99M | 5.80M | 11.93M | 6.87M | 5.07M | 4.60M | 3.76M | 3.05M | 3.06M | 4.88M | 3.37M | 3.26M | 3.44M | 9.76M | 6.21M | 4.86M | 5.37M | 5.24M | 5.11M | 5.08M | 5.38M | 4.07M | 2.80M | 3.70M | 6.50M | 5.30M | 9.50M |
| Other Expenses | -183.00K | -497.00K | -84.00K | 1.72M | 17.00K | -6.00K | -55.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.00K | 0.00 | 0.00 | 0.00 | 759.00K | 3.90M | 0.00 | 0.00 | 196.00K | 400.00K | 300.00K | 400.00K | 500.00K | 300.00K |
| Operating Expenses | 7.28M | 10.30M | 10.68M | 11.72M | 19.17M | 13.64M | 14.72M | 10.72M | 8.43M | 7.12M | 11.37M | 15.49M | 14.57M | 16.12M | 5.89M | 25.99M | 18.46M | 16.48M | 23.14M | 25.65M | 27.37M | 34.90M | 28.72M | 21.01M | 12.60M | 11.80M | 25.70M | 11.40M | 9.80M |
| Cost & Expenses | 7.46M | 10.30M | 10.88M | 12.19M | 20.46M | 14.18M | 14.72M | 10.72M | 8.43M | 7.12M | 11.37M | 15.49M | 14.57M | 16.12M | 5.89M | 25.99M | 18.46M | 16.48M | 23.14M | 25.65M | 27.37M | 34.90M | 28.72M | 20.81M | 12.20M | 11.50M | 25.30M | 10.90M | 9.50M |
| Interest Income | 5.00K | 53.00K | 1.00K | 769.00K | 967.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 646.00K | 717.00K | 570.00K | 673.00K | 1.28M | 4.22M | 6.76M | 5.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 1.00K | 769.00K | 967.00K | 887.00K | 369.00K | 37.00K | 0.00 | 0.00 | 1.57M | 4.86M | 6.43M | 678.00K | 6.00K | 470.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00M | 1.90M |
| Depreciation & Amortization | 112.00K | 196.00K | 221.00K | 292.00K | 244.00K | 380.00K | 417.00K | 377.00K | 358.00K | 353.00K | 107.00K | 17.00K | 32.00K | 85.00K | 169.00K | 210.00K | 288.00K | 389.00K | 405.00K | 466.00K | 439.00K | 1.57M | 647.00K | 196.00K | 400.00K | 300.00K | 400.00K | 500.00K | 300.00K |
| EBITDA | -7.17M | -10.04M | -9.13M | -7.06M | -6.28M | -7.88M | -14.09M | 4.72M | -6.40M | -3.12M | -784.00K | -8.35M | -10.51M | -6.07M | -5.65M | -25.22M | -18.15M | -16.06M | -22.65M | -25.54M | -26.84M | -30.43M | -23.50M | -18.74M | -11.50M | -11.20M | -7.40M | -10.00M | -9.10M |
| EBITDA Ratio | -3,894.02% | -16,731.67% | -641.81% | -110.42% | -496.70% | -135.65% | -6,839.07% | 26.32% | -112.57% | -115.03% | -123.60% | -117.37% | -300.07% | -57.55% | -7,064.56% | -35,357.14% | -76,187.50% | -50,159.38% | -25,466.29% | -77,738.71% | -25,786.52% | -1,038.52% | -512.38% | -730.21% | -3,800.00% | -12,000.00% | -92.00% | -3,266.67% | -8,700.00% |
| Operating Income | -7.28M | -10.24M | -9.35M | -7.35M | -16.84M | -8.26M | -14.50M | 4.34M | -6.76M | -3.48M | -891.00K | -8.37M | -10.51M | -6.03M | -5.82M | -25.92M | -18.43M | -16.45M | -23.05M | -26.38M | -31.17M | -32.00M | -24.15M | -18.93M | -11.90M | -11.40M | -7.80M | -10.60M | -9.40M |
| Operating Income Ratio | -3,954.89% | -17,058.33% | -612.98% | -151.94% | -466.46% | -139.81% | -6,745.12% | 28.83% | -404.49% | -95.31% | -8.50% | -117.61% | -258.26% | -59.69% | -7,360.76% | -37,028.57% | -76,804.17% | -51,396.88% | -25,900.00% | -85,096.77% | -35,026.97% | -1,106.60% | -528.22% | -1,007.13% | -3,966.67% | -11,400.00% | -44.57% | -3,533.33% | -9,400.00% |
| Total Other Income/Expenses | 1.71M | 29.00K | 578.00K | -56.00K | 386.00K | -759.00K | 195.00K | 792.00K | -4.52M | 1.07M | 10.60M | -6.81M | -4.70M | -809.00K | -71.00K | 490.00K | 786.00K | 710.00K | 589.00K | 376.00K | 1.29M | 3.82M | 6.69M | -5.01M | -100.00K | 999.00K | 8.70M | -400.00K | -400.00K |
| Income Before Tax | -5.57M | -10.21M | -8.78M | -7.41M | -16.46M | -9.02M | -14.31M | 5.14M | -11.28M | -2.40M | 9.71M | -15.18M | -15.20M | -6.83M | -5.88M | -25.43M | -17.65M | -15.74M | -22.46M | -26.00M | -29.89M | -28.18M | -17.46M | -23.94M | -12.00M | -10.50M | 900.00K | -10.90M | -9.80M |
| Income Before Tax Ratio | -3,026.63% | -17,010.00% | -575.10% | -153.10% | -455.77% | -152.65% | -6,654.42% | 34.09% | -674.99% | -65.91% | 92.65% | -213.29% | -373.72% | -67.71% | -7,443.04% | -36,328.57% | -73,529.17% | -49,178.13% | -25,238.20% | -83,883.87% | -33,583.15% | -974.48% | -381.98% | -1,273.62% | -4,000.00% | -10,500.00% | 5.14% | -3,633.33% | -9,800.00% |
| Income Tax Expense | 0.00 | -29.00K | -662.00K | 13.32M | -369.00K | -1.65M | -250.00K | -792.00K | 4.52M | -1.07M | -10.60M | 4.86M | 4.70M | 809.00K | 71.00K | 960.00K | -786.00K | -710.00K | -589.00K | 383.00K | 2.61M | -3.82M | -6.69M | -146.00K | -600.00K | -800.00K | -8.40M | 2.30M | 2.30M |
| Net Income | -5.57M | -10.18M | -8.11M | -20.73M | -16.09M | -9.02M | -14.31M | 5.14M | -11.28M | -2.40M | 9.71M | -15.18M | -15.20M | -6.83M | -5.89M | -25.43M | -17.65M | -15.74M | -22.46M | -26.00M | -29.89M | -28.18M | -17.46M | -18.79M | -11.30M | -10.60M | 600.00K | -12.90M | -11.70M |
| Net Income Ratio | -3,026.63% | -16,961.67% | -531.72% | -428.44% | -445.56% | -152.65% | -6,654.42% | 34.09% | -674.99% | -65.91% | 92.65% | -213.29% | -373.72% | -67.71% | -7,450.63% | -36,328.57% | -73,529.17% | -49,178.13% | -25,238.20% | -83,883.87% | -33,583.15% | -974.48% | -381.98% | -999.36% | -3,766.67% | -10,600.00% | 3.43% | -4,300.00% | -11,700.00% |
| EPS | -7.41 | -15.15 | -16.68 | -109.88 | -12.60K | -47.59 | -121.48 | 44.71 | -101.24 | -25.36 | 117.00 | -227.70 | -253.71 | -114.20 | -99.66 | -14.37 | -406.32 | -411.06 | -681.41 | -820.39 | -1.06K | -1.01K | -626.56 | -726.84 | -694.36 | -800.60 | 39.60 | -1.03K | -1.53K |
| EPS Diluted | -7.41 | -15.15 | -16.68 | -109.88 | -12.60K | -47.59 | -121.34 | 36.01 | -101.24 | -25.35 | 95.40 | -225.96 | -249.23 | -114.20 | -99.66 | -14.37 | -406.32 | -411.06 | -681.41 | -820.39 | -1.06K | -1.01K | -626.56 | -726.84 | -694.36 | -800.60 | 39.60 | -1.03K | -1.53K |
| Weighted Avg Shares Out | 752.00K | 671.70K | 486.50K | 188.65K | 1.28K | 189.60K | 117.78K | 115.21K | 111.40K | 94.76K | 82.93K | 66.67K | 59.92K | 59.85K | 59.06K | 1.77M | 43.43K | 38.28K | 32.96K | 31.70K | 28.19K | 27.92K | 27.87K | 25.85K | 16.27K | 13.24K | 15.15K | 12.52K | 7.64K |
| Weighted Avg Shares Out (Dil) | 752.00K | 671.70K | 486.50K | 188.65K | 1.28K | 189.60K | 117.91K | 119.21K | 111.40K | 94.78K | 83.49K | 67.18K | 61.00K | 59.85K | 59.06K | 1.77M | 43.43K | 38.28K | 32.96K | 31.70K | 28.19K | 27.92K | 27.87K | 25.85K | 16.27K | 13.24K | 15.15K | 12.52K | 7.64K |
Titan Pharmaceuticals Announces Reverse Stock Split
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board of Directors has approved a 1-for-30 reverse stock split of the Company's common stock, which will be...
TTNP Stock Price Increases 34.75%: Why It Happened
The stock price of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) has increased by 34.75% from $0.13 per share to $0.17 per share. This is an explanation of why it happened.
Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today reported financial results for the third quarter ended September 30, 2020 and provided an update on its business. Third Quarter 2020...
7 Penny Stocks to Watch in November
Penny stocks have become a popular investment alternative in 2020's volatile corona-economy. Here's a look at 7 penny stock to watch in November.
Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced the pricing of an underwritten public offering of 80,000,000 units at a price of $0.10 per unit. Each unit issued in the offering consists...
Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma Deal
Titan Pharmaceuticals (TTNP) is making news on Wednesday after announcing a deal with JT Pharma to acquire one of its assets. The post Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma Deal appeared...
Source: https://incomestatements.info
Category: Stock Reports